Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin.

Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin.

Item
http://www.wikidata.org/entity/Q30442041
Characterization of the antiplasmin activity of human thrombospondin-1 in solutionPlasmin modulates the thrombin-evoked calcium response in C6 glioma cells.Differences in the binding of transforming growth factor beta 1 to the acute-phase reactant and constitutively synthesized alpha-macroglobulins of rat.Proteinases are isoform-specific regulators of the binding of transforming growth factor beta to alpha 2-macroglobulin.Embryonic fibroblasts that are genetically deficient in low density lipoprotein receptor-related protein demonstrate increased activity of the urokinase receptor system and accelerated migration on vitronectin.Fibrin-targeted plasminogen activation by plasminogen activator, PadA, from Streptococcus dysgalactiae.Urokinase-type plasminogen activator and its receptor synergize to promote pathogenic proteolysis.Effects of extracellular DNA on plasminogen activation and fibrinolysis.Direct Host Plasminogen Binding to Bacterial Surface M-protein in Pattern D Strains of Streptococcus pyogenes Is Required for Activation by Its Natural Coinherited SK2b Protein.Insulin-like growth factor-binding protein-5 activates plasminogen by interaction with tissue plasminogen activator, independently of its ability to bind to plasminogen activator inhibitor-1, insulin-like growth factor-I, or heparin.Plasminogen activation by human keratinocytes: molecular pathways and cell-biological consequences.Stopped-flow fluorescence kinetics of bovine alpha 2-antiplasmin inhibition of bovine midiplasmin.Plasmin cleaves betaglycan and releases a 60 kDa transforming growth factor-beta complex from the cell surface.Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasminActivated thrombin-activatable fibrinolysis inhibitor reduces the ability of high molecular weight fibrin degradation products to protect plasmin from antiplasmin.A study of the protection of plasmin from antiplasmin inhibition within an intact fibrin clot during the course of clot lysis.The intrinsic threshold of the fibrinolytic system is modulated by basic carboxypeptidases, but the magnitude of the antifibrinolytic effect of activated thrombin-activable fibrinolysis inhibitor is masked by its instability.
P2860

Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin.

Item
http://www.wikidata.org/entity/Q30442041
description
1991 nî lūn-bûn
@nan
1991 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Soluble fibrin preparations in ...... a 2-antiplasmin and leupeptin.
@ast
Soluble fibrin preparations in ...... a 2-antiplasmin and leupeptin.
@en
type
label
Soluble fibrin preparations in ...... a 2-antiplasmin and leupeptin.
@ast
Soluble fibrin preparations in ...... a 2-antiplasmin and leupeptin.
@en
prefLabel
Soluble fibrin preparations in ...... a 2-antiplasmin and leupeptin.
@ast
Soluble fibrin preparations in ...... a 2-antiplasmin and leupeptin.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P478
P577
P5875
P698
P932
P356
P1433
P1476
Soluble fibrin preparations in ...... a 2-antiplasmin and leupeptin.
@en
P2093
P2860
P304
P31
P356
P407
P478
P577
P5875
P698
P932